Francesco De Rubertis

age:

55 years

appointments:

15 active

12 prior

primary industry:

Scientific research and development

about Francesco

Since 2019, Mr De Rubertis has been a director of 27 companies, the current directorship have a combined turnover of approximately £18.1m.

Combined Valuation

£528.4m

Combined Turnover

£18.1m

active directorships over time

company
turnover
valuation
start
end
status
role
centessa pharmaceuticals plc£5.4m£408.2mNov 2020-OpenDirector
centessa pharmaceuticals (uk) limited-£87.7mDec 2020-OpenDirector
levicept ltd£9.2m£5.6mNov 2020-OpenDirector
imhotex limited£218.1k£5.1mFeb 2020-OpenDirector
kaerus bioscience limited£191.5k£4.1mJun 2021-OpenDirector
perfect balance bio limited£383.2k£2.4mOct 2020-OpenDirector
ottimo pharma limited£384k£1.9mNov 2020-OpenDirector
ultrahuman thirteen limited£346.2k£583.9kNov 2020-OpenDirector
ultrahuman nine limited£342.3k£577.3kNov 2020-OpenDirector
ultrahuman ten limited£342.2k£577.1kNov 2020-OpenDirector
ultrahuman seven limited£308.5k£458.9kNov 2020-OpenDirector
pandeia therapeutics limited£148.8k£173.9kSep 2019-OpenDirector
z factor limited-£4Oct 2020-OpenDirector
bplete limited-£2Nov 2023-OpenDirector